Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 8, 2014 - Issue 6
Submit an article Journal homepage
558
Views
16
CrossRef citations to date
0
Altmetric
Drug Profile

Umeclidinium for the treatment of chronic obstructive pulmonary disease

Andrea SegretiDepartment of System Medicine, University of Rome Tor Vergata, Rome, Italy
,
Luigino CalzettaDepartment of Pulmonary Rehabilitation, IRCCS, San Raffaele Pisana Hospital, Rome, Italy
,
Paola RoglianiDepartment of System Medicine, University of Rome Tor Vergata, Rome, Italy
&
Mario CazzolaDepartment of System Medicine, University of Rome Tor Vergata, Rome, ItalyCorrespondence[email protected]
Pages 665-671 | Published online: 14 Oct 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Ingrid Fricke-Galindo & Ramcés Falfán-Valencia. (2022) Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?. Expert Review of Respiratory Medicine 16:11-12, pages 1145-1152.
Read now
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Josuel Ora & Maria Gabriella Matera. (2022) A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert Review of Clinical Pharmacology 15:3, pages 269-283.
Read now
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani & Mario Cazzola. (2018) A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17:5, pages 509-517.
Read now
Paola Rogliani, Maria Gabriella Matera, Josuel Ora, Mario Cazzola & Luigino Calzetta. (2017) The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3469-3485.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel. (2016) Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 167-192.
Read now

Articles from other publishers (10)

Ching-Fu Weng, Chien-Chih Wu, Mei-Hsuan Wu & Fang-Ju Lin. (2023) Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD. Chest 163:4, pages 799-814.
Crossref
Daiana Stolz & Mario Cazzola. 2020. Cardiovascular Complications of Respiratory Disorders. Cardiovascular Complications of Respiratory Disorders 238 250 .
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs & Afisi S. Ismaila. (2018) Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective. Cost Effectiveness and Resource Allocation 16:1.
Crossref
Han Ni, Aung Htet & Soe Moe. (2017) Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2017:6.
Crossref
Adeeb Bulkhi, Farnaz Tabatabaian & Thomas B. Casale. (2016) Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions. Drugs 76:10, pages 999-1013.
Crossref
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2016) Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update. Drug Safety 39:6, pages 501-508.
Crossref
Tara Rheault, Sanjeev Khindri, Mitra Vahdati-Bolouri, Alison Church & William A. Fahy. (2016) A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD . ERJ Open Research 2:2, pages 00101-2015.
Crossref
Hetal J. Patel. (2016) An update on pharmacologic management of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 22:2, pages 119-124.
Crossref
Maria Gabriella Matera & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 41 62 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.